Core Viewpoint - 弘海高新资源 has successfully completed a placement of 40.92 million shares at an adjusted price of HKD 0.335 per share, raising approximately HKD 13.7 million in total proceeds, with a net amount of about HKD 13.5 million after expenses [1] Group 1: Placement Details - The placement represents approximately 20.00% of the company's issued share capital prior to completion and about 16.67% after the issuance of the placement shares [1] - The net issue price for each placement share is approximately HKD 0.329 [1] Group 2: Use of Proceeds - Approximately HKD 3 million of the net proceeds will be allocated for exploration expenses, technical personnel costs, professional fees, and other related expenses for potential investment opportunities in the mining industry [1] - About HKD 10.5 million will be used for general working capital, including legal and professional fees necessary for business development, as well as daily operational expenses such as employee costs and other corporate expenditures [1]

Core Viewpoint - The company has entered into a placement agreement with an exclusive placement agent to sell a total of 45.921 million new H shares at a price of HKD 10.98 per share, aiming to enhance its financial strength and market competitiveness [1] Financial Details - The total expected proceeds from the placement, assuming full subscription, amount to HKD 504 million [1] - The net proceeds will be allocated as follows: 70% for the construction and equipment purchase of the second phase of the Changshu new production facility, 10% for the construction of a solid-state battery pilot line, 10% for research and development activities, and 10% for working capital and general corporate purposes [1] Strategic Objectives - The placement aims to strengthen the group's financial position, market competitiveness, and overall capabilities, promoting long-term sustainable development [1]

Core Viewpoint - The company has signed an agreement with a placement agent to issue up to 75.4743 million new shares at a placement price of HKD 0.180 per share, representing approximately 16.67% of the enlarged total share capital, with a discount of about 7.69% compared to the closing price on October 16, 2023 [1] Summary by Relevant Sections - **Share Placement Details** - The company plans to place a maximum of 75.4743 million new shares at a price of HKD 0.180 per share [1] - This placement accounts for approximately 16.67% of the total shares post-expansion [1] - The placement price reflects a discount of about 7.69% from the closing price of HKD 0.195 on October 16, 2023 [1] - **Use of Proceeds** - The expected net proceeds from the placement are approximately HKD 13.52 million [1] - The funds will be utilized for general working capital, including employee costs, professional fees, rent, and general administrative and operational expenses [1]

Core Viewpoint - China Shangcheng (02330) announced a placement agreement with a placement agent to issue up to 75.4743 million new shares at a price of HKD 0.180 per share, representing a discount of approximately 7.69% compared to the closing price of HKD 0.195 on October 16, 2025 [1] Group 1 - The placement shares represent about 16.67% of the enlarged issued share capital [1] - The estimated net proceeds from the placement are approximately HKD 13.52 million [1] - The company intends to use the net proceeds for general working capital, including employee costs, professional fees, rent, and general administrative and operational expenses [1]

Core Viewpoint - 惠陶集团 plans to place a maximum of 17.416 million shares, representing 16.66% of the enlarged total share capital, at a price of HKD 0.34 per share, which is approximately a 20% discount to the closing price of HKD 0.425 [1] Summary by Category - **Share Placement Details** - The company intends to issue up to 17.416 million shares [1] - The placement price is set at HKD 0.34 per share, reflecting a discount of about 20% from the last closing price [1] - **Financial Implications** - The placement is expected to raise a maximum of HKD 59.2 million, with net proceeds estimated at approximately HKD 54 million [1] - **Use of Proceeds** - The funds raised will be utilized for the company's current business operations, development, and general working capital [1]

Core Viewpoint - 惠陶集团 plans to issue up to 17,416,000 shares at a price of no less than HKD 0.34 per share, representing approximately 20% of the existing issued shares as of the announcement date [1] Group 1: Share Placement Details - The placement agreement was established with a placement agent, who will facilitate subscriptions from at least six investors during the placement period [1] - The placement price of HKD 0.34 represents a discount of about 20% compared to the closing price of HKD 0.425 on the date of the placement agreement [1] - The maximum gross proceeds from the placement are estimated to be approximately HKD 5.92 million [1] Group 2: Use of Proceeds - The net proceeds from the placement, after deducting the placement agent's commission, professional fees, and other related costs, are expected to be around HKD 5.4 million [1] - The funds will be utilized for current business operations, development, and general working capital expenditures [1]

Core Viewpoint - The announcement from 嘉鼎国际集团 (Jiadeng International Group) indicates the successful completion of a placement of new shares, which will enhance the company's operational funding [1] Group 1 - The board of 嘉鼎国际集团 has confirmed that all conditions for the placement have been met [1] - The placement was completed on October 15, 2025, involving the issuance of 3,851,686 new shares [1] - The net proceeds from the placement amount to approximately HKD 2.9 million, which will be used for general operational funding [1]

Core Viewpoint - Tiancheng Holdings (02110) has announced a placement agreement to issue up to 60 million shares at a price of HKD 0.1 per share, representing approximately 16.67% of the enlarged issued share capital, with a discount of about 13.79% from the closing price on the date of the agreement [1] Summary by Sections - **Placement Details** - The placement is expected to involve at least six independent third-party subscribers [1] - The total gross proceeds from the placement are estimated to be HKD 6 million, with a net amount of approximately HKD 5.71 million after expenses [1] - **Use of Proceeds** - The net proceeds from the placement will be used entirely for general working capital [1]

Group 1 - The company, 康特隆 (01912), has completed a placement agreement, successfully placing a total of 220 million shares [1] - The placement was finalized on October 10, 2025, with shares issued at a price of HKD 0.065 per share, representing approximately 16.67% of the enlarged issued share capital post-placement [1] - The net proceeds from the placement amount to approximately HKD 12.83 million, with plans to use at least HKD 10 million for debt repayment and the remaining for general working capital [1]

Core Viewpoint - InnoCare Pharma (02577) plans to issue 20.7 million new H-shares at a price of HKD 75.58 per share, representing a discount of approximately 7.88% from the closing price on October 9, 2023 [1] Summary by Categories Share Issuance - The proposed share issuance will account for approximately 3.94% of the enlarged H-share capital and about 2.26% of the total issued shares [1] Financial Details - The total expected proceeds from the share placement are approximately HKD 1.5645 billion, with net proceeds estimated at around HKD 1.5504 billion [1] Use of Proceeds - Approximately 31% of the net proceeds will be allocated for capacity expansion and continuous product upgrades - About 24% will be used to repay interest-bearing debts - Approximately 45% will be designated for working capital and general corporate purposes [1]